Disseminated Mycobacterium Bovis after Intravesicular Bacillus Calmette-Guérin Treatments for Bladder Cancer

Lamm D. . BCG immunotherapy for transitional-cell carcinoma in situ of the bladder. Oncology (Huntingt). 1995; 9: 947–952, 955-965 discussion and review.

Schellhammer P.F. , Ladaga L.E. , Fillion M.B. . Bacillus Calmette-Guérin for superficial transitional cell carcinoma of the bladder. J Urol. 1986; 135: 261–264.

Mungan N.A. , Witjes J.A. . Bacille Calmette-Guérin in superficial transitional cell carcinoma. Br J Urol. 1998; 82: 213–223. Review.

Lamm D.L. , Stogdill V.D. , Stogdill B.J. . Complications of bacillus Calmette-Guérin immunotherapy in 1,278 patients with bladder cancer. J Urol. 1986; 135: 272–274.

Lamm D.L. , van der Meijden P.M. , Morales A. . Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol. 1992; 147: 596–600.

Groves M.J. . Pharmaceutical characterization of Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine used for the treatment of superficial bladder cancer. J Pharm Sci. 1993; 82: 555–562. Review.

Bornet P. , Pujade B. , Lacaine F. . Tuberculous aneurysm of the femoral artery: a complication of bacilli Calmette-Guérin vaccine immunotherapy: a case report. J Vasc Surg. 1989; 10: 688–692.

Izes J.K. , Bihrle W III , Thomas C.B. . Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guérin. J Urol. 1993; 150(5 Pt 1): 1498–1500. Review.

Lamm D.L. . Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am. 1992; 19: 565–572. Review.

McParland C. , Cotton D.J. , Gowda K.S. . Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis. 1992; 146(5 Pt 1): 1330–1333.

Kesten S. , Title L. , Mullen B. . Pulmonary disease following intravesical BCG treatment. Thorax. 1990; 45: 709–710.

Talbot E.A. , Perkins M.D. , Silva S.F. . Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997; 24: 1139–1146. Review.

Kristjansson M. , Green P. , Manning H.L. . Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis. 1993; 17: 228–230.

Dederke B. , Riecken E.O. , Weinke T. . A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation. Infection. 1998; 26: 54–57.

Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med. 1998; 339: 831–837. Case 29-1998.

Molina J.M. , Rabian C. , D'Agay M.F. . Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guérin: successful treatment with steroids. J Urol. 1992; 147: 695–697.

Koukol S.C. , DeHaven J.I. , Riggs D.R. . Drug therapy of bacillus Calmette-Guérin sepsis. Urol Res. 1995; 22: 373–376.

Deresiewicz R.L. , Stone R.M. , Aster J.C. . Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guérin. J Urol. 1990; 144: 1331–1334.

Griggs H. , Cammarata S.K. . Acute mental changes in a 68-year-old man with bladder cancer. Chest. 1998; 114: 621–23.

Iantorno R. , Nicolai M. , Storto M.L. . Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guérin for superficial bladder cancer. J Urol. 1998; 159: 1639–1640.